BETA

Activities of José Inácio FARIA related to 2018/0161(COD)

Plenary speeches (1)

Supplementary protection certificate for medicinal products (A8-0039/2019 - Luis de Grandes Pascual) PT
2016/11/22
Dossiers: 2018/0161(COD)

Amendments (26)

Amendment 19 #
Proposal for a regulation
Recital 2
(2) By providing for a period of supplementary protection of up to five years, Regulation (EC) No 469/2009 seeks to promote, within the Union, the research and innovation that is necessary to develop medicinal products, and to contribute to Regulation (EC) No 469/2009 provided a uniform solution at Community level to prevent a heterogeneous evolution of national legislation creating new disparities, which could hinder the free movement of medicines within the Community and thus directly affect the functioning of the internal market. However, the medicines system in the EU has evolved in recent decades with the introduction of generic and biosimilar medicines which impreoventing the relocation of pharmaceutical research outside the Union to countries that may offer greater protection competitiveness, the sustainability of health systems and European citizens’ access to medicines, while the exception intended by the proposed amendment of this regulation provides an opportunity to improve the parameters referred to above, which are now under threat.
2018/10/17
Committee: ENVI
Amendment 23 #
Proposal for a regulation
Recital 2 a (new)
(2a) The proposal to amend the regulation so as to allow the production of generics and biosimilars for export and storage to make it possible for them to enter the European market when the patent expires does not conflict with intellectual property rights, as they do not interfere with the duration of market exclusivity rights during the patent, which is underscored by the fact that immediate import is allowed after expiry, but represents a competitive disadvantage for the European generic medicines industry.
2018/10/17
Committee: ENVI
Amendment 33 #
Proposal for a regulation
Recital 4
(4) The absence of any exception in Regulation (EC) No 469/2009 to the protection conferred by a supplementary protection certificate has had the unintended consequence of preventing manufacturers of generics and biosimilars established in the Union from manufacturing, even for the exclusive purpose of exporting to third country markets in which such protection does not exist or has expired. A further unintended consequence is that the protection conferred by the certificate makes it more difficult for those manufacturers to enter the Union market immediately after expiry of the certificate, given that they are not in a position to build up production capacity until the protection provided by the certificate has lapsed, by contrast with manufacturers located in third countries where protection does not exist or has expired.
2018/10/17
Committee: ENVI
Amendment 47 #
Proposal for a regulation
Recital 7
(7) The aim of this Regulation is to ensure that manufacturers established in the Union are able to compete effectively in those third country markets where supplementary protection does not exist or has expired. It is intended to complement the efforts of the Union’s trade policy to ensure open markets for Union-based manufacturers of medicinal products. Indirectly, it is also intended to put those manufacturers in a better position to enter the Union market immediately after expiry of the relevant supplementary protection certificate. It would also help to serve the aim of fostering access to medicines in the Union by helping to ensure a swifter entry of generic and biosimilar medicines onto the market after expiry of the relevant certificate.
2018/10/17
Committee: ENVI
Amendment 48 #
Proposal for a regulation
Recital 8
(8) In thoese specific and limited circumstances, and in order to creatit is appropriate to eliminate the aforementioned, unintended side effects of the supplementary protection certificate so as to enable a level -playing field between Union-based manufacturers and those in third country manufacturers, it is appropriate to restrict the protection conferred by aies. This would enable making exclusively for: (i) export to third countries, and (ii) entry onto the union market immediately after expiry of the relevant supplementary protection certificate so, as to allow making for the exclusive purpose of export to third countries andwell as any related acts strictly necessary for that making or for the actual export itself or that entry onto the Union market.
2018/10/17
Committee: ENVI
Amendment 59 #
Proposal for a regulation
Recital 9
(9) That exception should cover the making of the product, including the product which corresponds to the medicinal product protected by a supplementary protection certificate protected by a supplementary protection certificate, including the making of the corresponding medicinal product, in the territory of a Member State, for the exclusive purpose of export to third countries, as well as any upstream or downstream acts by the maker or by third parties in a contractual relationship with the maker where no supplementary protection certificate is in place and to prepare for the entry in the Union's market on the first day after patent expiration, as well as any upstream or downstream acts, where such acts would otherwise require the consent of the certificate-holder, and are strictly necessary for making for the purpose of export or, for the actual export itself or for the entry in the Union's market on the first day after patent expiration. For instance, such acts may include the supply and import of active ingredients for the purpose of making the corresponding medicinal product, to which the product covered by the certificate corresponds, or temporary storage of the product or advertising for the exclusive purpose of export to third country destinemporary storage of the product or medicinal product, advertising or other activities necessary for the purpose of actually exporting to country destinations where no supplementary protection certificate is in place or the entry in the Union's market on the first day after patent expirations.
2018/10/17
Committee: ENVI
Amendment 67 #
Proposal for a regulation
Recital 10
(10) The exception should not cover placing thea medicinal product made for the exclusive purpose of export on the marketr for the entry in the Union's market on the first day after patent expiration in the Member State where a supplementary protection certificate is in force, either directly or indirectly after export, nor should it cover re-importation of the medicinal product to the market of a Member State in which a certificate is in force. Moreover, it should not cover any act or activity for the purpose of import of medicinal products, or parts of medicinal products, into the Union merely for the purposes of repackaging and re-exporting.
2018/10/17
Committee: ENVI
Amendment 72 #
Proposal for a regulation
Recital 11
(11) By limiting the scope of the exception to making for the purposes of export outside the Union andentry in the Union's market on the first day after patent expiration and export to countries where no supplementary protection certificate is in place as well as to prepare for the acts strictly necessary for such making or for the actual export itself, the exception introduced by this Regulation will not unreasonably conflict with normal exploitation of the product or medicinal product in the Member State where the certificate is in force, nor unreasonably prejudice the legitimate interests of the certificate-holder, taking account of the legitimate interests of third parties.
2018/10/17
Committee: ENVI
Amendment 80 #
Proposal for a regulation
Recital 12
(12) Safeguards should accompany the exception in order to increase transparency, to help the holder of a supplementary protection certificate to enforce its protection in the Union and to reduce the risk of illicit diversion onto the Union market during the term of the certificate.deleted
2018/10/17
Committee: ENVI
Amendment 90 #
Proposal for a regulation
Recital 13
(13) To this end, this Regulation should impose a once-off duty on the person making the product for the exclusive purpose of export, requiring that person to provide certain information to the authority which granted the supplementary protection certificate in the Member State where the making is to take place. The information should be provided before the making is intended to start for the first time in that Member State. The making and related acts, including those performed in Member States other than the one of making in cases where the product is protected by a certificate in those other Member States too, should only fall within the scope of the exception where the maker has sent this notification to the competent industrial property authority (or other designated authority) of the Member State of making. The once-off duty to provide information to the authority should apply in each Member State where making is to take place, both as regards the making in that Member State, and as regards related acts, whether performed in that or another Member State, related to that making. The authority should be required to publish that information, in the interests of transparency and for the purpose of informing the holder of the certificate of the maker’s intention.deleted
2018/10/17
Committee: ENVI
Amendment 104 #
Proposal for a regulation
Recital 14
(14) In addition, this Regulation should impose certain due diligence requirements on the maker as a condition for the exception to operate. The maker should be required to inform persons within its supply chain, through appropriate means, in particular contractual means, that the product is covered by the exception introduced by this Regulation and is intended for the exclusive purpose of export. A maker who failed to comply with these due diligence requirements would not benefit from the exception, nor would any third party performing a related act in the same or a different Member State where a certificate conferring protection for the product was in force, and the holder of the relevant certificate would therefore be entitled to enforce its rights under the certificate.deleted
2018/10/17
Committee: ENVI
Amendment 113 #
Proposal for a regulation
Recital 15
(15) Furthermore, this Regulation should impose labelling requirements on the maker, in order to facilitate, by means of a logo, identification of the product as a product exclusively intended for the purpose of export to third countries. The making and related acts should only fall outside the protection conferred by a supplementary protection certificate if the product is labelled in this manner. This labelling obligation would be without prejudice to labelling requirements of third countries.deleted
2018/10/17
Committee: ENVI
Amendment 120 #
Proposal for a regulation
Recital 19
(19) In order to ensure that holders of supplementary protection certificates already in force are not deprived of their acquired rights, the exception provided for in this Regulation should only apply to certificates that are granted on or after a specified date after entry into force, irrespective of when the application for the certificate was first lodged. The date specified should allow a reasonable time for applicants and other relevant market players to adjust to the changed legal context and to make appropriate investment and manufacturing location decisions in a timely way. The date should also allow sufficient time for public authorities to put in place appropriate arrangements to receive and publish notifications of the intention to make, and should take due account of pending applications for certificates.deleted
2018/10/17
Committee: ENVI
Amendment 134 #
Proposal for a regulation
Recital 21
(21) It is necessary and appropriate for the achievement of the basic objective, of providing a level playing field for generic and biosimilar manufacturers with their competitors in third country markets where protection does not exist or has expired, to lay down rules restricting the exclusive right of a supplementary protection certificate holder to make the product in question during the term of the certificate, and also to impose certain information and labelling obligations on makers wishing to take advantage of those rulesenabling the making of the product in question during the term of the certificate. This Regulation complies with the principle of proportionality, and does not go beyond what is necessary in order to achieve the objectives pursued, in accordance with Article 5(4) of the Treaty on European Union.
2018/10/17
Committee: ENVI
Amendment 139 #
Proposal for a regulation
Recital 22
(22) This Regulation respects fundamental rights and observes the principles recognised by the Charter of Fundamental Rights of the European Union. In particular, this Regulation seeks to ensure full respect for the right to property in Article 17 of the Charter by maintaining the core rights of the supplementary protection certificate, by confining the exception to certificates granted on or after a specified date after entry into force of this Regulation and by imposing certain conditions on the application of the exceptionthe right to healthcare in Article 35 of the Charter by making medicines more accessible to EU patients, the principle of proportionality in Article 52 of the Charter, point (a) of Article 6 TFEU on the right to health protection for European citizens,
2018/10/17
Committee: ENVI
Amendment 144 #
2. The certificate referred to in paragraph 1 shall not confer protection against a particular acts against which the basic patent conferred protection if, with respect to that particular act, the following conditions are met:
2018/10/17
Committee: ENVI
Amendment 149 #
Proposal for a regulation
Article 1 – paragraph 1 – point 1
Regulation (EU) No 469/2009
Article 4 – paragraph 2 – point a – point i
(i) making for the exclusive purpose(s) of export to third countries; and/or entry into the market of Member States immediately after expiry of the certificate in those member states; and/or
2018/10/17
Committee: ENVI
Amendment 158 #
(ii) any related act that is strictly necessary for that making or for the actual export itself, for the export and/or for effectively entering the market of the Member States immediately after expiry of the certificate in those Member States;
2018/10/17
Committee: ENVI
Amendment 165 #
Proposal for a regulation
Article 1 – paragraph 1 – point 1
Regulation (EU) No 469/2009
Article 4 – paragraph 2 – point b
(b) the authority referred to in Article 9(1) of the Member State where that making is to take place (‘the relevant Member State’) is notified by the person doing the making (‘the maker’) of the information listed in paragraph 3 no later than 28 days before the intended start date of making in that Member State;deleted
2018/10/17
Committee: ENVI
Amendment 181 #
Proposal for a regulation
Article 1 – paragraph 1 – point 1
Regulation (EU) No 469/2009
Article 4 – paragraph 2 – point c
(c) the maker ensures that a logo, in the form set out in Annex -I, is affixed to the outer packaging of the product or, if there is no outer packaging, to its immediate packaging;deleted
2018/10/17
Committee: ENVI
Amendment 187 #
Proposal for a regulation
Article 1 – paragraph 1 – point 1
Regulation (EU) No 469/2009
Article 4 – paragraph 3
3. The information for the purposes of paragraph 2(b) shall be as follows: (a) the name and address of the maker; (b) the address, or addresses, of the premises where the making is to take place in the relevant Member State; (c) the number of the certificate granted in the relevant Member State, and identification of the product, by reference to the proprietary name used by the holder of that certificate; (d) the number of the authorisation granted in accordance with Article 40(1) of Directive 2001/83/EC or Article 44(1) of Directive 2001/82/EC for the manufacture of the corresponding medicinal product or, in the absence of such authorisation, a valid certificate of good manufacturing practice as referred to in Article 111(5) of Directive 2001/83/EC or Article 80(5) of Directive 2001/82/EC covering the premises where the making is to take place; (e) the intended start date of making in the relevant Member State; (f) an indicative list of the intended third country or third countries to which the product is to be exported.deleted
2018/10/17
Committee: ENVI
Amendment 208 #
Proposal for a regulation
Article 1 – paragraph 1 – point 1
Regulation (EU) No 469/2009
Article 4 – paragraph 4
4. The maker shall ensure, through appropriate means, that persons in a contractual relationship with the maker who perform acts falling within paragraph 2(a)(ii) are fully informed and aware of the following: (a) that those acts are subject to the provisions of paragraph 2; (b) that the placing on the market, import or re-import of the product might infringe the certificate referred to in that paragraph where, and as long as, that certificate applies.deleted
2018/10/17
Committee: ENVI
Amendment 214 #
Proposal for a regulation
Article 1 – paragraph 1 – point 1
Regulation (EU) No 469/2009
Article 4 – paragraph 5
5. Paragraph 2 shall apply in the case only of certificates granted on or after [OP: please insert the date of the first day of the third month that follows the month in which this amending Regulation is published in the Official Journal)].only to activities carried out after the entry into force of the present Regulation;
2018/10/17
Committee: ENVI
Amendment 223 #
Proposal for a regulation
Article 1 – paragraph 1 – point 2
Regulation (EU) No 469/2009
Article 11 – paragraph 4
(2) in Article 11, the following paragraph is added: ‘4. The notification sent to an authority as referred to in Article 4(2)(b) shall be published by that authority within 15 days of receipt of the notification.;’deleted
2018/10/17
Committee: ENVI
Amendment 229 #
Proposal for a regulation
Article 1 – paragraph 1 – point 4
Regulation (EU) No 469/2009
Article 21a – paragraph 4
(4) the Annex to this Regulation is inserted as Annex -I.deleted
2018/10/17
Committee: ENVI
Amendment 231 #
Proposal for a regulation
Annex I
Regulation (EU) No 469/2009
Annex I
THIS SUBHEADING IS MISSING. THANK YOU FOR USING ANOTHER LANGUAGE. Logo null ’deleted
2018/10/17
Committee: ENVI